Daxor - 15 Year Stock Price History | DXR
Historical daily share price chart and data for Daxor since 2011 adjusted for splits and dividends. The latest closing stock price for Daxor as of September 16, 2026 is 11.71.
- The all-time high Daxor stock closing price was 23.78 on July 17, 2020.
- The Daxor 52-week high stock price is 14.76, which is 26% above the current share price.
- The Daxor 52-week low stock price is 8.56, which is 26.9% below the current share price.
- The average Daxor stock price for the last 52 weeks is 11.52.
| Daxor Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 10.9448 | 14.3600 | 14.3600 | 8.8700 | 11.7150 | -20.58% |
| 2025 | 9.9128 | 7.5500 | 14.7500 | 7.0500 | 14.7500 | 91.81% |
| 2024 | 8.9581 | 9.5000 | 10.0300 | 7.1900 | 7.6900 | -19.90% |
| 2023 | 9.4653 | 9.0000 | 13.0300 | 7.2640 | 9.6000 | 4.80% |
| 2022 | 11.8391 | 11.0002 | 14.2260 | 9.1000 | 9.1602 | -18.83% |
| 2021 | 11.0872 | 12.4066 | 14.1500 | 8.7700 | 11.2850 | -9.72% |
| 2020 | 13.8132 | 9.2900 | 23.7800 | 8.6000 | 12.5000 | 32.98% |
| 2019 | 10.6191 | 9.1100 | 19.5200 | 7.5000 | 9.4000 | 14.63% |
| 2018 | 6.2802 | 4.3889 | 13.8900 | 3.5216 | 8.2000 | 80.59% |
| 2017 | 6.0589 | 8.3868 | 9.0741 | 3.9961 | 4.5406 | -44.17% |
| 2016 | 7.9563 | 7.3741 | 9.3485 | 7.2266 | 8.1328 | 8.84% |
| 2015 | 6.9881 | 7.0039 | 8.7353 | 5.3703 | 7.4724 | 9.44% |
| 2014 | 6.9636 | 6.6220 | 8.3552 | 5.9305 | 6.8278 | 2.64% |
| 2013 | 7.0851 | 7.3682 | 7.8033 | 6.5772 | 6.6522 | -9.48% |
| 2012 | 8.3468 | 8.9473 | 9.4663 | 7.3005 | 7.3488 | -14.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.065B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |